Mereo BioPharma Announces Listing Transfer to Nasdaq Capital Market
05.05.2023 - LONDON, May 05, 2023 (GLOBE NEWSWIRE) - Mereo BioPharma Group plc (NASDAQ: MREO) (“Mereo” or the “Company”), a clinical-stage biopharmaceutical company focused on rare diseases, today announced that it has received approval from Listing ... Seite 1